Porojnicu Alina Carmen, Lagunova Zoya, Robsahm Trude Eid, Berg Jens Petter, Dahlback Arne, Moan Johan
Department of Radiation Biology, Institute for Cancer Research, Montebello, 0310 Oslo, Norway.
Breast Cancer Res Treat. 2007 May;102(3):323-8. doi: 10.1007/s10549-006-9331-8. Epub 2006 Sep 21.
The Norwegian counties can conveniently be divided in three groups with different annual UV exposures and different incidence rates of squamous cell carcinoma (SCC) of the skin. In view of the hypothesis that latitude and season of diagnosis may play a role for breast cancer progression, the prognosis of breast cancer as determined for summer and winter diagnosis, were evaluated in the three residential regions. Two age groups were analysed separately (stratification at 50 years). For all regions, and for all ages, the prognosis was best for women diagnosed in the summer season (Relative risk (RR) of death was 15-25% lower for summer diagnosis versus winter diagnosis). There was no significant seasonal variation of the number of new cases. For women diagnosed before the age of 50, a geographical gradient in cancer prognosis was also found (RR of death 0.6, 95% CI: 0.5-0.7 for cases diagnosed in southeast Norway and RR of death 0.8, 95% CI: 0.6-1.1 for diagnosis in the north of Norway). This is in agreement with a 1.5 times larger annual UV exposures and 3-4 times larger incidence rates of SCC in the southeast region when compared with the north region. For women diagnosed after the age of 50, no significant difference was found between the three regions. Despite a 17% higher vitamin D intake from food in north of Norway no difference in cancer survival was found for diagnosis during winter (when no significant differences in the levels of UV exposure can be detected between regions). The overall data support our earlier hypothesis that season of diagnosis and therapy start improves the survival for breast cancer.
挪威的各个郡可以方便地分为三组,它们的年紫外线暴露量不同,皮肤鳞状细胞癌(SCC)的发病率也不同。鉴于纬度和诊断季节可能对乳腺癌进展有影响这一假设,在这三个居住区域评估了夏季和冬季诊断的乳腺癌预后。对两个年龄组分别进行了分析(以50岁为分层界限)。对于所有区域和所有年龄的女性,夏季诊断的患者预后最佳(夏季诊断与冬季诊断相比,死亡相对风险(RR)低15 - 25%)。新病例数没有明显的季节性变化。对于50岁之前诊断出乳腺癌的女性,还发现了癌症预后的地理梯度(挪威东南部诊断的病例,死亡RR为0.6,95%置信区间:0.5 - 0.7;挪威北部诊断的病例,死亡RR为0.8,95%置信区间:0.6 - 1.1)。这与东南部地区的年紫外线暴露量比北部地区大1.5倍以及SCC发病率高3 - 4倍相一致。对于50岁之后诊断出乳腺癌的女性,三个区域之间未发现显著差异。尽管挪威北部从食物中摄入的维生素D高出17%,但在冬季诊断时未发现癌症生存率存在差异(此时各区域之间的紫外线暴露水平没有显著差异)。总体数据支持我们之前的假设,即诊断和治疗开始的季节可改善乳腺癌患者的生存率。